COVID-19 positive individuals with a moderate to severe risk of OSA exhibited lower serum IL-6 levels (median 4, IQR 28) compared to individuals with a mild risk of OSA (median 21, IQR 38, p < 0.05). Here, IL6 is linked to COVID-19.